China's vaccine scandal highlights HK's special status
IN MID-JULY, China's state drug administration ordered Changsheng Bio-technology, a company headquartered in Changchun, in northeastern China, to stop production of rabies vaccines after it uncovered evidence of forged data.
At about the same time, the company was fined 3.4 million yuan (S$678,512) for the production of inferior DPT vaccines last year.
As soon as the news got out, mothers on the mainland reacted. One Shenzhen resident, 33-year-old Emily Liu, made an urgent appointment in Hong Kong for her five-year-old son to be vaccinated. Within 48 hours, he had received a booster shot of a four-in-one vaccine against diphtheria, tetanus, whooping cough and polio.
TRENDING NOW
Why US$100 oil, 5% US yields affect Singdollar, ringgit differently vs other Asean currencies
He built the Vingroup empire. Now South-east Asia’s richest man is handing some key roles to his sons
Asia needs new energy security architecture
CDL to launch 570-unit Jurong project Lucerne Grand with prices from S$1.5 million
